Psoriatic Arthritis Clinical Trial

About This Study

This clinical trial is evaluating an investigational medication designed to address both the joint and skin manifestations of psoriatic arthritis. The study aims to determine whether this dual-action therapy can reduce joint pain and swelling while also improving psoriasis skin symptoms.

Psoriatic arthritis is an inflammatory condition that affects both joints and skin. Many patients struggle to find treatments that effectively address both aspects of the disease. This study explores a potentially more comprehensive approach.

Learn more about psoriatic arthritis at Overlake Arthritis →

Who May Qualify?

• Have been diagnosed with psoriatic arthritis
• Have active joint symptoms (3+ affected joints)
• Have current or history of psoriasis skin lesions
• Are between 18 and 70 years old
• Are willing to attend study visits over approximately 12 months

What Participation Involves

• Screening: Complete medical evaluation including joint and skin assessments
• Study Visits: Approximately 10-12 visits over 12 months
• Medication: Investigational therapy targeting both joint and skin symptoms
• Monitoring: Regular assessments of joints, skin, and overall health

Compensation

Qualified participants receive compensation for time and travel. All study-related care is provided at no cost.

Check Your Eligibility

Answer a few quick questions to see if you may qualify. This screening is completely confidential.